BEVYXXA
Peakbetrixaban
NDAORALCAPSULEPriority Review
Approved
Jun 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
7
Clinical Trials (5)
BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes
Started Sep 2018
0Venous Thromboses
Study Evaluating Betrixaban in Pediatric Participants
Started Jul 2018
21 enrolled
VTE Prophylaxis
A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
Started Sep 2015
52 enrolled
Healthy
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing
Started Aug 2015
18 enrolled
Bleeding
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Started Mar 2012
7,513 enrolled
Venous Thromboembolism (VTE)
Loss of Exclusivity
LOE Date
Mar 29, 2031
61 months away
Patent Expiry
Mar 29, 2031
External Resources